Why Moderna Stock Blasted 13% Higher Today
Yahoo Finance18:36 ET
Moderna's Sales From Its Only Product, the COVID-19 Vaccine, Fell 91% From Last Year
Yahoo Finance17:21 ET
Moderna Options Spot-On: On May 2nd, 132.6K Contracts Were Traded, With 296.75K Open Interest
On May 2nd ET, $Moderna(MRNA.US)$ had active options trading, with a total trading volume of 132.6K options for the day, of which put options accounted for 34.77% of the total transactions, and call o
moomoo News16:30 ET
Novo Nordisk Slides While Moderna Pops: Tale of Two Pharma Stocks
Yahoo Finance16:17 ET
Research Alert: CFRA Retains Hold Opinion On Shares Of Moderna, Inc.
CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We up our target price to $115 from $88
MT Newswires16:15 ET
Equity Markets Higher Ahead of Apple Earnings
US benchmark equity indexes were higher ahead of Thursday's close, as investors awaited Apple's (AAPL) results. The technology-heavy Nasdaq Composite was up 1.4% at 15,821.9, while the S&P 500 rose 0.
MT Newswires15:51 ET
S&P 500, Nasdaq Rise Intraday Amid Moderna Rally as Traders Await Apple Results
The S&P 500 and the Nasdaq Composite were higher intraday, buoyed by a post-earnings rally in Moderna's (MRNA) stock, as investors awaited Apple's (AAPL) results. The technology-heavy Nasdaq was up 1.
MT Newswires14:23 ET
Sector Update: Health Care Stocks Retreat Thursday Afternoon
Health care stocks were declining Thursday afternoon, with the NYSE Health Care Index shedding 0.6% and the Health Care Select Sector SPDR Fund (XLV) down 0.2%. The iShares Biotechnology ETF (IBB) ros
MT Newswires13:59 ET
RBC Raises Price Target on Moderna to $135 From $125
Moderna (MRNA) has an average rating of outperform and price targets ranging from $60 to $310, according to analysts polled by Capital IQ. Price: 124.26, Change: +12.80, Percent Change: +11.48
MT Newswires13:55 ET
J.P. Morgan Downgrades Metagenomi Over Moderna Deal Termination
Seeking Alpha13:46 ET
Sector Update: Health Care
Health care stocks were declining Thursday afternoon, with the NYSE Health Care Index shedding 0.6% and the Health Care Select Sector SPDR Fund (XLV) down 0.2%. The iShares Biotechnology ETF (IBB) ros
MT Newswires13:38 ET
Wall Street Inches Up Post Fed; Chipmakers Rebound; Gold, Crude Falter: What's Driving Market Thursday?
U.S. stock markets surged during Thursday's midday trading session in New York, with major averages all showing gains.Trader sentiment rebounded thanks to positive signals from corporate earnings and
Benzinga13:37 ET
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities.Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scan
Benzinga13:35 ET
Express News | Needham Reiterates Hold on Moderna
Benzinga13:18 ET
Moderna Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/02/2024 — Needham Reiterates → Hold 04/11/2024 — Needham Reiterates → Hold 04/09/2024 2.5% Jefferies
Benzinga13:17 ET
Moderna Reports Smaller Than Expected Q1 Loss, Prepares For RSV Vaccine And Spikevax 2024-2025 Formula, Stock Soars
Thursday, Moderna Inc (NASDAQ:MRNA) reported a first-quarter EPS loss of $(3.07), down from an income of $(0.19), smaller than the consensus estimate loss of $(3.55).The company reported sales of $167
Benzinga13:12 ET
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
After topping expectations with first quarter revenue and adjusted earnings last week, Merck & Co Inc (NYSE:MRK) just reported encouraging data from its Phase III gastric cancer treatment trial after
Benzinga12:53 ET
Top Stock Movers Now: Moderna, Wayfair, Peloton Interactive, and More
Investopedia12:43 ET
Earnings Call Summary | Moderna(MRNA.US) Q1 2024 Earnings Conference
The following is a summary of the Moderna, Inc. (MRNA) Q1 2024 Earnings Call Transcript:Financial Performance:Moderna reported Q1 2024 revenues of $167 million, mainly from respiratory vaccine sales.T
moomoo AI12:18 ET · Conference Call
Express News | Metagenomi Shares Are Trading Lower After Moderna and the Company Mutually Agreed to Terminate Their Collaboration on Primary Hyperoxaluria Type 1 and Rights to Develop the PH1 Program. Also, JP Morgan Downgraded the Stock From Overweight to Neutral and L
BenzingaMay 2 11:58 ET
No Data
No Data